skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 
Home » Regular Columns » Three Quick Facts » Three Quick Facts: Hornby, Blue Star Capital and MyHealthChecked

Here are three things you need to know in the financial markets this morning from investment writer, Tony Cross.

News seems in short supply this morning, but it’s the calm ahead of tomorrow’s flurry of earnings updates we’re expecting from retailers.

#1. Hornby looking towards digital transformation with new appointment?

A note from Hornby [LON:HRN] advises that a new non-executive director – Henry de Zoete – has agreed to join the firm. This is interesting on two counts, with the company’s shares having rallied hard yesterday and also given the incoming NED’s experience in technology companies. Mr de Zoete’s achievements include establishing Look After My Bills and he is expected to play a key role in the digital transformation of Hornby.

#2. Blue Star Capital play down share price rise

Blue Star Capital [LON:BLU] was also on our radar last night having seen its shares spar during yesterday’s session. The company has however issued a statement this morning saying it knows of no reason why the price has been marching higher – market speculation that an update was imminent may still look a bit premature but this remains worth watching.

#3. MyHealthChecked announces deal to supply Lloyds Pharmacies

Rounding off, MyHealthChecked [LON:MHC] has this morning announced a deal to supply Lloyds Pharmacies with pre-departure rapid antigen tests. These accompany the portfolio of PCR test kits already on offer from the pharmacy chain and will allow passengers to take tests at home prior to travel or before returning, with results verified by a professional within two hours. There is however speculation that testing before returning to the UK could be scrapped as soon as this week, which may temper upside potential here.

Please note this article does not constitute investment advice. Investors are encouraged to do their own research beforehand or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we are following most closely. They all represent significant growth stories in our view. Our in-depth reports go into more detail on why we like them.

Comments

Subscribe for more stories like this, 8am weekdays - for free!


Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

Pepperstone
FP Markets
IG
Spreadex
WisdomTree
ActivTrades
Back To Top